Quipt Home Medical (NASDAQ:QIPT) and PAVmed (NASDAQ:PAVM) Head to Head Contrast
Quipt Home Medical (NASDAQ:QIPT) and PAVmed (NASDAQ:PAVM) Head to Head Contrast
PAVmed (NASDAQ:PAVM – Get Rating) and Quipt Home Medical (NASDAQ:QIPT – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, profitability and valuation.
Earnings and Valuation
This table compares PAVmed and Quipt Home Medical's gross revenue, earnings per share and valuation.
Get PAVmed alerts:Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
PAVmed | $380,000.00 | 93.73 | -$88.98 million | ($1.01) | -0.36 |
Quipt Home Medical | $139.86 million | 1.67 | $4.84 million | $0.20 | 32.40 |
Quipt Home Medical has higher revenue and earnings than PAVmed. PAVmed is trading at a lower price-to-earnings ratio than Quipt Home Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares PAVmed and Quipt Home Medical's net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
PAVmed | N/A | -172.76% | -79.69% |
Quipt Home Medical | 4.83% | 9.94% | 5.78% |
Volatility & Risk
PAVmed has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.
Institutional and Insider Ownership
14.0% of PAVmed shares are owned by institutional investors. Comparatively, 26.1% of Quipt Home Medical shares are owned by institutional investors. 13.2% of PAVmed shares are owned by company insiders. Comparatively, 4.2% of Quipt Home Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current recommendations and price targets for PAVmed and Quipt Home Medical, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
PAVmed | 0 | 1 | 1 | 0 | 2.50 |
Quipt Home Medical | 0 | 0 | 3 | 0 | 3.00 |
PAVmed currently has a consensus price target of $3.56, suggesting a potential upside of 884.39%. Quipt Home Medical has a consensus price target of $11.75, suggesting a potential upside of 81.33%. Given PAVmed's higher possible upside, research analysts plainly believe PAVmed is more favorable than Quipt Home Medical.
Summary
Quipt Home Medical beats PAVmed on 10 of the 14 factors compared between the two stocks.
About PAVmed
(Get Rating)
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. Its products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. The company was founded on June 26, 2014 and is headquartered in New York, NY.
About Quipt Home Medical
(Get Rating)
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company also provides bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, nebulizers and compressors, oxygen concentrators, patient lifts, walkers, wheelchairs, and products for wound care. In addition, it offers ventilators; home-based sleep apnea and chronic obstructive pulmonary disease treatments; home-based healthcare logistics and services; medical supplies, medical equipment, mobility equipment, and respiratory equipment; and CPAP and BiPAP units, ventilation equipment and aids, daily and ambulatory aides, and equipment solutions, as well as home and hospital delivery, and oxygen therapy services. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.
納斯達克:PAVM-GET Rating)和Quipt Home Medical(納斯達克:QIPT-GET Rating)都是小盤醫療公司,但哪一家更好?我們將根據分析師推薦的風險、收益、股息、機構所有權、盈利能力和估值對這兩家公司進行比較。
收益和估值
此表比較了PAVmed和Quipt Home Medical的總收入、每股收益和估值。
到達PAVmed警報:總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 本益比 | |
PAVmed | 380,000.00美元 | 93.73 | -8,898萬元 | (1.01美元) | -0.36 |
Quipt Home Medical | 1.3986億美元 | 1.67 | 484萬美元 | 0.20美元 | 32.40 |
Quipt Home Medical的收入和收益比PAVmed更高。PAVmed的本益比低於Quipt Home Medical,表明它目前是兩只股票中更負擔得起的一隻。
盈利能力
此表比較了PAVmed和Quipt Home Medical的淨利潤率、股本回報率和資產回報率。
淨利潤率 | 股本回報率 | 資產回報率 | |
PAVmed | 不適用 | -172.76% | -79.69% |
Quipt Home Medical | 4.83% | 9.94% | 5.78% |
波動性與風險
PAVmed的貝塔係數為0.88,表明其股價的波動性比標準普爾500指數低12%。相比之下,Quipt Home Medical的貝塔係數為0.6,表明其股價的波動性比標準普爾500指數低40%。
機構和內部人持股
PAVmed 14.0%的股份由機構投資者持有。相比之下,Quipt Home Medical 26.1%的股份由機構投資者持有。PAVmed 13.2%的股份由公司內部人士持有。相比之下,Quipt Home Medical 4.2%的股份由公司內部人士持有。強大的機構持股表明,大型基金管理公司、對沖基金和捐贈基金相信,一隻股票的長期表現將好於大盤。
分析師建議
這是由MarketBeat.com提供的PAVmed和Quipt Home Medical的當前建議和目標價格的細目。
銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
PAVmed | 0 | 1 | 1 | 0 | 2.50 |
Quipt Home Medical | 0 | 0 | 3. | 0 | 3.00 |
PAVmed目前的共識目標價為3.56美元,暗示潛在上行884.39%。Quipt Home Medical的共識目標價為11.75美元,暗示潛在上行空間為81.33%。考慮到PAVmed更有可能的上行空間,研究分析師顯然認為PAVmed比Quipt Home Medical更有利。
摘要
Quipt Home Medical在兩只股票比較的14個因素中有10個超過了PAVmed。
關於PAVmed
(獲取評級)
PAVmed,Inc.是一家商業階段的技術醫療器械公司,致力於醫療技術的商業化。它通過以下部門運作:醫療設備、診斷、數位健康和新興創新。其產品包括細胞採集設備、食道DNA測試、腕管釋放、植入性骨內血管接入設備和抗菌可吸收耳管。該公司成立於2014年6月26日,總部設在紐約州紐約。
關於Quipt Home Medical
(獲取評級)
Quipt Home Medical Corp.在美國提供家庭醫療設備和用品,以及呼吸和耐用醫療設備。它提供各種慢性疾病狀態的管理,重點是心臟和肺部疾病、睡眠呼吸暫停、行動不便和其他慢性健康狀況的患者。該公司還提供減肥設備、浴室安全產品、雙水準氣道正壓、柺杖/柺杖、持續氣道正壓、CPAP口罩和配件、醫院病床、加濕器、霧化器和壓縮機、氧氣濃縮器、病人降升機、助行器、輪椅和傷口護理產品。此外,它還提供呼吸機;家庭睡眠呼吸暫停和慢性阻塞性肺疾病治療;家庭醫療物流和服務;醫療用品、醫療設備、移動設備和呼吸設備;CPAP和BiPAP設備、通風設備和輔助設備、日常和門診輔助設備、設備解決方案,以及家庭和醫院遞送服務,以及氧療服務。該公司前身為Protech Home Medical Corp.,並於2021年5月更名為Quipt Home Medical Corp.。Quipt Home Medical Corp.成立於1993年,總部設在肯塔基州懷爾德。
接受PAVmed日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對PAVmed和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧